STAT2 and neoplasm: Tumor immune escape and the initiation of metastasis promote oncogenesis and tumor progression.[35] Moreover, the tumor microenvironment is significantly associated with therapeutic response and survival of patients.[36] STAT2 in KIRC was found to be associated with the LYN and LCK kinases network.